Alternatives to salmeterol
FDA shortage status is active for salmeterol; 3 same-class SPL records are listed below for registry comparison only.
Brand: Serevent
salmeterol class peers while FDA lists an active shortage
salmeterol (Serevent) is on an FDA shortage listing while 3 other Long-Acting Beta-2 Agonist (LABA) SPL records remain in this registry peer set (class inventory 4).
FAERS top-reaction fields are thin or absent for salmeterol in this extract; peer cards still expose SPL indication and OTC/Rx flags.
About salmeterol
3 Long-Acting Beta-2 Agonist (LABA) peers (wide set)
formoterol
RxForadil, Perforomist
Formoterol inhalation solution is used to treat chronic obstructive pulmonary disease (COPD). COPD includes chronic bronchitis and emphysema. This medicine helps to lessen the tightening of your airways, making it easier to breathe. It is for long-term use and should be taken twice a day.
indacaterol
RxArcapta Neohaler
olodaterol
RxStriverdi Respimat
Striverdi Respimat is used long-term to treat COPD, including chronic bronchitis and emphysema. It helps to open up the airways in your lungs, making it easier to breathe. This medicine is not for sudden COPD symptoms or for asthma.
salmeterol shortage vs Long-Acting Beta-2 Agonist (LABA) peer index
Shortage status
FDA shortage listing is active for salmeterol (status: To Be Discontinued). Peer rows remain a registry index, not a switch guide.
Frequently Asked Questions
Does FDA list a shortage for salmeterol while peers remain indexed? ▼
Registry note: Shortage listings and peer indexes are for registry orientation only. This information is for educational purposes only and is not a substitute for professional medical advice. Do not stop or change your medication without talking to your doctor or pharmacist.
Field note for salmeterol: see also the generic vs brand label guide when reading Serevent SPL strings.
Read our methodology - how this data is sourced, computed, and verified.